Survival for thyroid cancer

Survival depends on many factors. No one can tell you exactly how long you will live.

Below are general statistics based on large groups of people. Remember, they can’t tell you what will happen in your individual case. 

Your doctor can give you more information about your own outlook (prognosis). You can also talk about this with the Cancer Research UK information nurses on freephone 0808 800 4040, from 9am to 5pm, Monday to Friday.

Survival is generally very good for papillary and follicular thyroid cancers. Papillary thyroid cancer is the most common type of thyroid cancer. 

About these statistics

The terms 1 year survival and 5 year survival don't mean that you will only live for 1 or 5 years.

The NHS, other health organisations, and researchers collect information. They watch what happens to people with cancer in the years after their diagnosis. 5 years is a common time point to measure survival. But some people live much longer than this.

5 year survival is the number of people who have not died from their cancer within 5 years after diagnosis.

Survival for all types and stages of thyroid cancer

There are no UK-wide statistics available for thyroid cancer survival by stage. Survival statistics are available for all stages of thyroid cancer in England. These statistics are for people diagnosed between 2016 and 2020. There are some differences between men and women:

1 year survival

  • around 90 out of every 100 men (around 90%) survive thyroid cancer for at least 1 year after diagnosis
  • almost 95 out of every 100 women (almost 95%) survive thyroid cancer for at least 1 year after diagnosis

5 year survival

  • Around 85 out of every 100 men (around 85%) survive thyroid cancer for at least 5 years after diagnosis
  • 90 out of every 100 women (90%) survive thyroid cancer for at least 5 years after diagnosis

10 year survival

  • Around 85 out of every 100 people (around 85%) survive their cancer for 10 years or more after diagnosis

Survival for different types of thyroid cancer

The survival statistics below are from a large European study. They are based on people treated in the UK and Ireland between 2000 and 2007. Treatments improve over time, so people treated now may have a better outlook. 

With thyroid cancer, the most important factor that affects survival is the type and stage of thyroid cancer you have.

More than 85 out of every 100 men (more than 85%) survive their cancer for 5 years or more after they are diagnosed.

Almost 95 out of 100 women (almost 95%) survive their cancer for 5 years or more after they are diagnosed.

Around 85 out of every 100 men (around 85%) will survive their cancer for 5 years or more after they are diagnosed.

Almost 90 out of every 100 women (almost 90%) will survive their cancer for 5 years or more after they are diagnosed.

Almost 70 out of every 100 men (almost 70%) will survive their cancer for 5 years or more after they are diagnosed.

Around 75 out of every 100 women (around 75%) will survive their cancer for 5 years or more after they are diagnosed.

Around 5 out of every 100 men (around 5%) will survive their cancer for 5 years or more after they are diagnosed.

Around 5 out of every 100 women (around 5%) will survive their cancer for 5 years or more after diagnosis.

What affects survival?

Your outlook depends on the type and stage of your thyroid cancer when it’s diagnosed. Stage means how big it is and whether it has spread. The outcome is usually better when the cancer is at an early stage.  

Your likely survival is also affected by your age. Survival is better in younger men and women.

If you have other medical conditions, this might influence the treatment you can have. It might also affect your likely survival.

  • Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5
    L Dal Maso and others
    European Journal of Cancer, 2017. Volume 77, Pages 140-152

  • Cancer survival by stage at diagnosis for England, 2019
    Office for National Statistics

  • The impact of age and gender on papillary thyroid cancer survival 
    J Jonklaas and others
    Journal of Clinical Endocrinology and Metababolism, 2012. Volume 97, Issue 6, Pages E878-87

Last reviewed: 
14 Jul 2023
Next review due: 
14 Jul 2026

Related links